Write a detailed Notes on Neuromuscular blockers from Stolteings pharma, Miller's Barash Morgan for MD Anaesthesiology exam
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
These notes are now synthesized from all three textbooks you specified. Here is a summary of what's covered:
What These Notes Cover
The notes are organized into 15 major sections drawing directly from Miller's Anesthesia 10e, Barash, Cullen & Stoelting's Clinical Anesthesia 9e, and Morgan & Mikhail's Clinical Anesthesiology 7e:
- History - Griffith (1942), Beecher & Todd mortality data (1954)
- NMJ Anatomy and Physiology - receptor subunits (adult α2βδε vs fetal α2βγδ), quantal ACh release
- Classification - by mechanism, chemical class, duration
- Succinylcholine in depth - mechanism, Phase I/II block, pseudocholinesterase/dibucaine number, all side effects (hyperkalemia, IOP, ICP, masseter rigidity, MH, myalgia, fasciculations), contraindications
- Nondepolarizing agents - mechanism, potency-onset relationship (key Miller principle)
- Individual drugs - rocuronium, vecuronium, pancuronium, atracurium, cisatracurium, mivacurium with full pharmacokinetic tables
- Pharmacokinetics comparison table (exam-ready)
- Neuromuscular monitoring - TOF, PTC, DBS, tetanus; TOF ≥0.9 standard
- Factors affecting blockade - renal/hepatic/burns/aging/neonates, temperature, pH, drug interactions (volatile agents, antibiotics, anticonvulsants)
- Reversal - neostigmine ceiling effect vs sugammadex doses (2/4/16 mg/kg)
- Residual block - incidence (30-50%), clinical consequences, monitoring
- Special situations - RSI, CICO management, ICU use, pediatrics
- Autonomic effects table
- 18 high-yield exam facts and mnemonics
- Clinical exam scenarios with answers
This is a shared conversation. Sign in to Orris to start your own chat.